Search Results 651-660 of 19269 for Hemoglobin

1. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

   DLCO corrected for hemoglobin 30% to 79% of predicted, inclusive. Exclusion Criteria: History of acute exacerbation of IPF or respiratory tract infection ...

2. A Study to Compare the Effectiveness, Safety and Tolerability of P1101 vs. Anagrelide for Essential Thrombocythemia - Mayo Clinic

   ... hemoglobin (HGB) <10 g/dL at any dose and any duration of HU, or Presence of HU-related toxicities at any dose and any duration of therapy (e.g., leg ulcers ...

3. The Use of the Cerebral Oximetry for Patients Undergoing Dynamic Computed Tomography Myelography under General Anesthesia - Mayo Clinic

   Systemic hemodynamic data (ie, heart rate, systemic blood pressure, peripheral hemoglobin oxygen saturation); Cerebral oximetric data recorded at 2 minute ...

4. A Study of Bezisterim (NE3107) in Adults with Long COVID - Mayo Clinic

   Hemoglobin ≤ 10 g/dL if female, ≤11.5 g/dL if male; International normalized ratio (INR) > 1.5 if not on anticoagulant medication; if the participant is on ...

5. A Study of 9-ING-41 in Patients with Advanced Cancers - Mayo Clinic

   hemoglobin ≥ 8.5 g/dL, platelets ≥ 50,000/mL 2. Adequate liver function: transaminases (aspartate aminotransferase/ alanine aminotransferase, AST/ALT) and ...

6. Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer - Mayo Clinic

   Hemoglobin > 9.0 g/dL; Total serum bilirubin ≤ 2 mg/dL; Aspartate transaminase (AST) ≤ 2.5 x upper limit of normal (ULN) (≤ 5 x ULN in patients with liver ...

7. Nephrotic syndrome - Symptoms & causes - Mayo Clinic

   Swelling around your feet and ankles is a common sign of this condition that occurs when your kidneys pass too much protein in your urine.

8. A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Adequate hematology laboratory results (absolute neutrophil count ≥ 1.5 x 10^9/L, platelet count ≥ 75 x 10^9/L, hemoglobin ≥ 10.0 g/dL). Adequate ...

9. Aortic Valve Repair And Aortic Valve Replacement Clinical Trials - Mayo Clinic Research

   The purpose of this study is to test if a reduction of hemoglobin leads to subclinical cardiac dysfunction in patients with known cardiovascular disease. .

10. A Study to Evaluate Injectafer® as Treatment for Heart Failure with Iron Deficiency - Mayo Clinic

    Hemoglobin > 9.0 g/dL and < 13.5 g/dL (females) or < 15.0 g/dL (males) within 28 days of randomization. Serum ferritin < 100 ng/mL or 100 to 300 ng/mL with ...